Balance Sheet - Amneal Pharmaceuticals, Inc. (AMRX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 310.87 | 112.42 | 93.74 | 27.80 | 248.96 | 343.07 | 152.32 | 215.54 | 76.02 | 31.72 | 66.06 | 0.00 |
| Accounts receivable, net | 939.87 | 775.73 | 645.66 | 741.79 | 694.74 | 639.00 | 604.39 | 565.32 | 351.37 | 394.79 | 273.83 | |
| Inventories | 606.30 | 612.45 | 581.38 | 530.74 | 489.39 | 490.65 | 381.07 | 457.22 | 284.04 | 266.16 | 234.97 | |
| Other current assets | 54.13 | 87.20 | 57.08 | 111.50 | 88.19 | 78.82 | 72.43 | 98.14 | 62.36 | 33.45 | 29.74 | |
| Total current assets | 1,911.18 | 1,587.81 | 1,377.86 | 1,411.82 | 1,520.11 | 1,551.54 | 1,210.21 | 1,286.64 | 771.93 | 726.11 | 604.60 | |
| Total non-current assets | 1,767.10 | 1,913.64 | 2,094.71 | 2,387.52 | 2,419.56 | 2,454.49 | 2,455.68 | 3,066.09 | 569.96 | 481.77 | 398.34 | |
| Total assets | 3,678.28 | 3,501.45 | 3,472.57 | 3,799.34 | 3,939.66 | 4,006.03 | 3,665.89 | 4,352.74 | 1,341.89 | 1,218.82 | 1,014.09 | 1,922.49 |
| Total current liabilities | 881.63 | 1,129.77 | 846.60 | 752.80 | 677.24 | 676.90 | 550.41 | 553.85 | 296.88 | 225.07 | 239.15 | |
| Total non-current liabilities | 2,790.68 | 2,416.21 | 2,564.67 | 2,837.61 | 2,895.45 | 2,972.40 | 2,768.70 | 2,902.52 | 1,420.59 | 1,159.57 | 951.62 | |
| Total liabilities | 3,672.32 | 3,545.98 | 3,411.27 | 3,590.41 | 3,572.69 | 3,649.30 | 3,319.10 | 3,456.37 | 1,717.47 | 1,394.76 | 1,200.97 | |
| Total stockholders' equity | -70.79 | -109.27 | 19.78 | 298.42 | 360.34 | 303.27 | 232.01 | 896.36 | -385.74 | -185.29 | -195.14 | |
| Common shares outstanding | 325 | 309 | 176 | 151 | 152 | 149 | 132 | 127 | 115 | 189 | 189 | 189 |
Show Quarterly Balance Sheet
Balance Sheet - Amneal Pharmaceuticals, Inc. (AMRX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | Dec-17 | Sep-17 | Jun-17 | Mar-17 | Dec-16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 197.66 | 310.87 | 201.25 | 81.19 | 59.19 | 112.42 | 74.01 | 47.22 | 48.46 | 93.74 | 92.05 | 112.64 | 147.98 | 27.80 | 89.50 | 93.67 | 212.07 | 248.96 | 304.77 | 279.61 | 452.10 | 343.07 | 281.98 | 268.95 | 405.61 | 152.32 | 212.74 | 54.89 | 63.95 | 215.54 | 166.81 | 63.83 | 48.20 | 76.02 | 19.35 | 0.00 | 31.72 | 31.72 |
| Accounts receivable, net | 902.65 | 939.87 | 924.14 | 849.27 | 800.29 | 775.73 | 786.23 | 803.38 | 704.05 | 645.66 | 690.95 | 674.74 | 545.76 | 741.79 | 628.74 | 688.85 | 538.31 | 662.58 | 627.95 | 652.02 | 530.60 | 639.00 | 743.35 | 583.13 | 763.44 | 604.39 | 518.11 | 634.67 | 640.21 | 565.32 | 659.39 | 645.92 | 349.18 | 351.37 | 340.07 | 407.35 | ||
| Inventories | 641.62 | 606.30 | 614.50 | 608.97 | 601.43 | 612.45 | 596.36 | 575.62 | 570.65 | 581.38 | 576.47 | 550.56 | 529.04 | 530.74 | 543.86 | 533.03 | 512.24 | 489.39 | 520.25 | 523.39 | 497.01 | 490.65 | 475.76 | 443.96 | 437.96 | 381.07 | 401.83 | 414.63 | 448.29 | 457.22 | 490.77 | 512.48 | 327.89 | 284.04 | 277.75 | 266.16 | ||
| Other current assets | 55.98 | 54.13 | 98.59 | 45.27 | 49.54 | 87.20 | 56.70 | 59.26 | 56.89 | 57.08 | 96.60 | 83.85 | 84.54 | 111.50 | 157.73 | 238.05 | 127.06 | 119.17 | 117.37 | 108.47 | 79.96 | 78.82 | 38.42 | 187.64 | 168.70 | 72.43 | 73.16 | 81.66 | 115.52 | 98.14 | 134.31 | 147.40 | 50.17 | 62.36 | 56.35 | 10.18 | ||
| Total current assets | 1,797.91 | 1,911.18 | 1,838.48 | 1,584.69 | 1,510.45 | 1,587.81 | 1,513.29 | 1,485.48 | 1,380.04 | 1,377.86 | 1,456.08 | 1,421.79 | 1,307.33 | 1,411.82 | 1,419.83 | 1,553.60 | 1,389.68 | 1,520.11 | 1,570.34 | 1,563.48 | 1,559.66 | 1,551.54 | 1,543.72 | 1,480.87 | 1,773.70 | 1,210.21 | 1,205.83 | 1,185.85 | 1,267.97 | 1,286.64 | 1,431.30 | 1,347.89 | 48.20 | 771.93 | 693.51 | 31.72 | 726.11 | |
| Total non-current assets | 1,742.31 | 1,767.10 | 1,761.40 | 1,838.10 | 1,854.80 | 1,913.64 | 1,947.68 | 2,024.44 | 2,076.35 | 2,094.71 | 2,231.00 | 2,279.10 | 2,319.28 | 2,387.52 | 2,454.21 | 2,487.80 | 2,499.29 | 2,419.56 | 2,404.07 | 2,459.58 | 2,400.41 | 2,454.49 | 2,493.82 | 2,575.88 | 2,617.10 | 2,455.68 | 2,498.11 | 3,076.29 | 3,116.62 | 3,066.09 | 3,150.75 | 3,196.69 | 564.45 | 569.96 | 529.08 | 481.77 | ||
| Total assets | 3,540.22 | 3,678.28 | 3,599.87 | 3,422.79 | 3,365.25 | 3,501.45 | 3,460.98 | 3,509.92 | 3,456.40 | 3,472.57 | 3,687.08 | 3,700.89 | 3,626.61 | 3,799.34 | 3,874.04 | 4,041.41 | 3,888.97 | 3,939.66 | 3,974.41 | 4,023.05 | 3,960.07 | 4,006.03 | 4,037.54 | 4,056.76 | 4,390.80 | 3,665.89 | 3,703.94 | 4,262.14 | 4,384.59 | 4,352.74 | 4,582.05 | 4,544.59 | 1,358.79 | 1,341.89 | 1,239.61 | 1,218.82 | 1,218.82 | 1,218.82 |
| Total current liabilities | 728.05 | 881.63 | 862.11 | 1,107.13 | 1,075.82 | 1,129.77 | 1,095.21 | 1,114.35 | 834.39 | 846.60 | 760.60 | 777.35 | 703.71 | 752.80 | 818.00 | 993.06 | 602.04 | 677.24 | 667.34 | 672.86 | 636.78 | 676.90 | 667.89 | 655.02 | 965.07 | 550.41 | 534.91 | 546.16 | 599.53 | 553.85 | 749.27 | 669.74 | 313.05 | 296.88 | 259.24 | 225.07 | ||
| Total non-current liabilities | 2,858.14 | 2,790.68 | 2,847.72 | 2,362.39 | 2,348.81 | 2,416.21 | 2,399.45 | 2,399.64 | 2,638.62 | 2,564.67 | 2,735.10 | 2,740.66 | 2,760.70 | 2,837.61 | 2,839.38 | 2,857.47 | 2,863.10 | 2,878.54 | 2,908.65 | 2,945.81 | 2,956.58 | 2,972.40 | 3,021.45 | 3,030.72 | 3,022.28 | 2,768.70 | 2,773.31 | 2,966.63 | 2,985.28 | 2,902.52 | 2,917.46 | 2,935.37 | 1,392.19 | 1,420.59 | 1,398.20 | 1,159.57 | ||
| Total liabilities | 3,586.19 | 3,672.32 | 3,709.83 | 3,469.52 | 3,424.64 | 3,545.98 | 3,494.66 | 3,513.99 | 3,473.00 | 3,411.27 | 3,495.70 | 3,518.01 | 3,464.41 | 3,590.41 | 3,657.38 | 3,850.53 | 3,465.14 | 3,555.78 | 3,575.98 | 3,618.67 | 3,593.36 | 3,649.30 | 3,689.34 | 3,685.74 | 3,987.34 | 3,319.10 | 3,308.22 | 3,512.79 | 3,584.81 | 3,456.37 | 3,666.73 | 3,605.10 | 1,727.61 | 1,717.47 | 1,665.82 | 1,394.76 | ||
| Total stockholders' equity | -45.41 | -70.79 | -109.46 | -112.53 | -131.67 | -109.27 | -93.43 | -57.47 | -63.72 | 19.78 | 330.86 | 318.17 | 294.41 | 298.42 | 297.47 | 280.33 | 391.13 | 360.34 | 350.51 | 346.11 | 323.02 | 303.27 | 301.04 | 306.00 | 318.38 | 232.01 | 395.72 | 459.66 | 472.21 | 896.36 | 501.11 | 494.50 | 0.00 | -385.74 | -436.61 | -185.29 | -185.29 | |
| Common shares outstanding | 329 | 325 | 325 | 322 | 324 | 310 | 310 | 319 | 307 | 244 | 160 | 155 | 152 | 151 | 151 | 151 | 150 | 149 | 149 | 152 | 151 | 148 | 148 | 147 | 148 | 142 | 131 | 128 | 128 | 127 | 128 | 127 | 115 | 115 | 115 | 115 | 115 | 115 |